ClinConnect ClinConnect Logo
Search / Trial NCT04073420

Medtronic Cardiac Surgery PMCF Registry

Launched by MEDTRONIC CARDIAC SURGERY · Aug 28, 2019

Trial Information

Current as of August 23, 2025

Recruiting

Keywords

ClinConnect Summary

The Medtronic Cardiac Surgery PMCF Registry is a study designed to gather information about patients who have valve disease or are undergoing heart surgery. The goal of this registry is to monitor the safety and effectiveness of certain medical devices used in these treatments after they have been approved for use. Researchers are currently looking for participants to join the study, and anyone can participate regardless of gender.

To be eligible, patients must give written consent to take part and either have already received or be planning to receive a specific medical device related to their heart condition. Participants should be available for follow-up visits, and they cannot be involved in other studies that might interfere with the results. If you join this registry, you can expect to share your experiences with the treatment and receive regular check-ins from the research team to monitor your progress and health outcomes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
  • 2. Patient has or is intended to receive or be treated with an eligible product
  • 3. Patient is within enrollment window of treatment/therapy received at the time of their initial Registry enrollment, or meets criteria for retrospective enrollment
  • Exclusion Criteria:
  • 1. Patient who is, or is expected to be, inaccessible for follow-up
  • 2. Patient prohibited from participation by local law
  • 3. Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or device study that may confound results

About Medtronic Cardiac Surgery

Medtronic Cardiac Surgery is a leading global sponsor dedicated to advancing innovative solutions in cardiac care. With a focus on enhancing patient outcomes and surgical efficacy, Medtronic develops cutting-edge medical devices and technologies that address complex cardiovascular conditions. The organization is committed to rigorous clinical research and trials, ensuring that its products meet the highest standards of safety and efficacy. By collaborating with healthcare professionals and institutions worldwide, Medtronic Cardiac Surgery aims to transform the landscape of cardiac surgery, ultimately improving the quality of life for patients around the globe.

Locations

Ann Arbor, Michigan, United States

New York, New York, United States

Durham, North Carolina, United States

Marietta, Georgia, United States

Roslyn, New York, United States

Cleveland, Ohio, United States

Leiden, , Netherlands

Düsseldorf, , Germany

Athens, , Greece

Leuven, , Belgium

Pittsburgh, Pennsylvania, United States

Pessac, , France

Bern, , Switzerland

Leipzig, , Germany

Dresden, , Germany

Bad Rothenfelde, , Germany

Houston, Texas, United States

Falls Church, Virginia, United States

München, , Germany

Wien, , Austria

Plano, Texas, United States

Hamburg, , Germany

Massa, , Italy

San Donato, , Italy

Syracuse, New York, United States

Málaga, , Spain

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials